Verenium (NASDAQ: VRNM) and Calgon Carbon (NYSE:CCC) are both small-cap companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, profitability, valuation, dividends and earnings.
Risk and Volatility
Verenium has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Calgon Carbon has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500.
This table compares Verenium and Calgon Carbon’s revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Calgon Carbon||$619.81 million||1.76||$21.10 million||N/A||N/A|
Calgon Carbon has higher revenue and earnings than Verenium.
Calgon Carbon pays an annual dividend of $0.20 per share and has a dividend yield of 0.9%. Verenium does not pay a dividend.
This table compares Verenium and Calgon Carbon’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Institutional & Insider Ownership
92.5% of Calgon Carbon shares are held by institutional investors. 2.3% of Calgon Carbon shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
This is a summary of current ratings and recommmendations for Verenium and Calgon Carbon, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Calgon Carbon has a consensus target price of $20.83, suggesting a potential downside of 3.10%. Given Calgon Carbon’s higher possible upside, analysts plainly believe Calgon Carbon is more favorable than Verenium.
Calgon Carbon beats Verenium on 9 of the 9 factors compared between the two stocks.
Verenium Corporation (Verenium) is an industrial biotechnology company. The Company develops and commercializes enzymes for use in a range of industrial processes. It manufactures and markets its enzyme products in the fields of animal health and nutrition, grain processing, oilfield services and other industrial processes, such as pulp and paper and textiles. As of December 31, 2012, it marketed commercial enzyme products, either independently or in collaboration with its partners. In addition, it has developed a pipeline of enzyme product candidates. Its products are organized into four product lines: animal health and nutrition, grain processing, oilfield services and other industrial processes. As of December 31, 2012, it markets nine commercial enzyme products. In October 2013, BASF SE acquired 71% stake in the Company.
About Calgon Carbon
Calgon Carbon Corporation is a manufacturer of activated carbon, with capabilities in ultraviolet (UV) light disinfection. The Company provides purification solutions for drinking water, wastewater, pollution abatement, and a range of industrial and commercial manufacturing processes. The Company operates through four segments: Activated Carbon and Service, Equipment, Consumer and Other. The Company’s products and services are designed to protect human health and the environment from harmful contaminants in water, and air. The Company provides purification solutions for drinking water, wastewater, pollution abatement, and a range of industrial and commercial manufacturing processes. The Company operates in the United States, Europe, Japan, Africa, Canada, China, India, Latin America, and in other parts of Asia.
Receive News & Ratings for Verenium Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verenium and related companies with MarketBeat.com's FREE daily email newsletter.